Innovation and evaluation of surgery in research
In this session we’ll discuss evaluation of innovation in surgery. We’ll hear from the lead authors of two trials published in The Lancet this year “Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy” and “Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial”. You’ll hear from the authors, Richard Bulbulia, Alison Halliday, Geltrude Mingrone and Francesco Rubino respectively, about the trial design, barriers they faced and lessons learnt followed by a panel discussion and open Q&A to explore how we evaluate innovation chaired by Jessamy Bagenal from The Lancet.